Volume 141, Issue 4, Pages e5 (October 2011)

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 66, Issue 5, Pages (May 2017)
Volume 137, Issue 4, Pages e8 (October 2009)
Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung  Journal of Ginseng Research 
Volume 142, Issue 4, Pages (April 2012)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 16, Issue 5, Pages (November 2012)
Volume 133, Issue 2, Pages (August 2007)
Volume 146, Issue 2, Pages e3 (February 2014)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 15, Issue 1, Pages (January 2012)
Volume 15, Issue 5, Pages (May 2012)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Volume 154, Issue 3, Pages e8 (February 2018)
Volume 136, Issue 1, Pages e8 (January 2009)
Volume 146, Issue 5, Pages (May 2014)
Volume 8, Issue 4, Pages (October 2008)
Volume 102, Issue 6, Pages (September 2000)
Volume 137, Issue 6, Pages e2 (December 2009)
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Volume 16, Issue 10, Pages (September 2016)
Volume 64, Issue 1, Pages (January 2016)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 140, Issue 5, Pages (May 2011)
Volume 143, Issue 3, Pages (September 2012)
Volume 129, Issue 5, Pages (November 2005)
Volume 20, Issue 5, Pages (November 2014)
Volume 155, Issue 2, Pages (August 2018)
Volume 150, Issue 5, Pages (May 2016)
Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
Volume 141, Issue 4, Pages e2 (October 2011)
Volume 150, Issue 4, Pages (April 2016)
Volume 138, Issue 2, Pages e1 (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 142, Issue 4, Pages (April 2012)
Volume 136, Issue 4, Pages (April 2009)
Volume 7, Issue 3, Pages (March 2008)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 143, Issue 6, Pages e8 (December 2012)
Volume 13, Issue 8, Pages (November 2015)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 137, Issue 1, Pages (July 2009)
Volume 18, Issue 13, Pages (March 2017)
Volume 133, Issue 4, Pages e3 (October 2007)
Volume 138, Issue 7, Pages e3 (June 2010)
Volume 16, Issue 5, Pages (November 2012)
Volume 61, Issue 6, Pages (December 2014)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 134, Issue 4, Pages (April 2008)
Volume 134, Issue 4, Pages (April 2008)
Volume 132, Issue 5, Pages (May 2007)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 139, Issue 2, Pages e1 (August 2010)
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 135, Issue 4, Pages (October 2008)
Volume 137, Issue 4, Pages (October 2009)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 137, Issue 5, Pages (November 2009)
Volume 127, Issue 3, Pages (September 2004)
Volume 10, Issue 1, Pages (July 2009)
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Volume 10, Issue 5, Pages (November 2009)
Volume 19, Issue 2, Pages (February 2014)
Volume 141, Issue 5, Pages (November 2011)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 9, Issue 4, Pages (April 2009)
Volume 1, Issue 5, Pages (May 2005)
Presentation transcript:

Volume 141, Issue 4, Pages 1393-1403.e5 (October 2011) Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis  Derrick M. Van Rooyen, Claire Z. Larter, W. Geoffrey Haigh, Matthew M. Yeh, George Ioannou, Rahul Kuver, Sum P. Lee, Narci C. Teoh, Geoffrey C. Farrell  Gastroenterology  Volume 141, Issue 4, Pages 1393-1403.e5 (October 2011) DOI: 10.1053/j.gastro.2011.06.040 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Increased hepatic cholesterol levels and LDLR expression in foz/foz mice with NASH. (A) Hepatic CE and (B) FC content in normal chow (0% [wt/wt] cholesterol) and HF (0.2% [wt/wt] cholesterol)-fed WT and foz/foz mice at 12 weeks (white bars) and 24 weeks (black bars) (n = 5–10 per group; see Materials and Methods) as determined by high-performance liquid chromatography. (C) LDLR protein expression, normalized to heat shock protein 90 (HSP90) expression. (D) Representative LDLR IHC staining from 24-week liver sections. Arrows indicate positive staining. Scale bars = 50 μm. *P < .05 vs diet-matched control. #P < .05 vs genotype-matched control. †P < .05 vs time-matched control. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Decreased cholesterol and BA biosynthesis as well as canalicular transporter gene expression in HF-fed foz/foz versus WT mice. (A) Microsomal HMGR activity at 12 weeks (white bars) and 24 weeks (black bars) in foz/foz and WT mice according to diet (values for n are in Materials and Methods). (B) ACAT-2 protein, (C) CE hydrolase (CEH) mRNA, and (D) Cyp7a1 mRNA expression at 12 and 24 weeks. (E) Hepatic bile salt exporter protein (Bsep) and (F) ATP-binding cassette protein G8 (ABCG8) protein expression at 12 and 24 weeks. Heat shock protein 90 (HSP90) (shown in F) was used as a loading control but not shown in all panels for clarity (results for loading controls were similar). Same mice as in Figure 1. *P < .05 versus diet-matched control. #P < .05 versus genotype-matched control. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Effect of diet and genotype on hepatic expression of nuclear regulators involved in cholesterol homeostasis. (A) SREBP-2, (B) LRH-1, (C) FXR, and (D) Shp expression at 12 weeks (white bars) and 24 weeks (black bars) was assessed using Western blotting of isolated hepatic nuclear protein. TATA-box binding protein (TBP) (shown in B) was used as a loading control. Same mice as preceding figures. *P < .05 versus diet-matched control. #P < .05 versus genotype-matched control. †P < .05 versus time-matched control. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Insulin alters cholesterol-regulating protein expression in primary hepatocyte cultures. (A) Levels of SREBP-2, (B) LDLR, and (C) bile salt exporter protein (Bsep) expression in primary hepatocytes (whole cell lysates) treated with 0, 0.2, 6.5, and 13.0 ng/mL insulin for 48 hours (n = 3/group). As shown in D, protein expression was normalized to β-actin. (E) LRH-1 and (F) Shp mRNA were assessed by reverse-transcription polymerase chain reaction. There was insufficient material to prepare nuclear protein extracts. This experiment was conducted 3 times with analyses in triplicate (n = 9 per group total). *P < .05 between groups. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Dietary cholesterol modulates hepatic cholesterol content and liver injury but not other lipid profiles in NASH. (A) Serum ALT, (B) total hepatic CE, and (C) hepatic FC content in WT (white bars) and foz/foz (black bars) mice (n values as per Materials and Methods) fed HF diet containing 0, 0.2%, or 2.0% (wt/wt) cholesterol for 24 weeks. (D) Hepatic triglycerides (TG), (E) diacylglycerides (DAG), and (F) total FFAs as determined by high-performance liquid chromatography. *P < .05 versus diet-matched control. #P < .05 versus genotype-matched, 0.0% cholesterol group. †P < .05 versus genotype-matched, 0.2% cholesterol group. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 Dietary cholesterol modulates hepatocyte apoptosis and macrophage recruitment in NASH. (A) Cell death, as assessed by cytokeratin-18 (Ck-18) fragmentation, and (B) macrophage cell recruitment (F4/80) were determined using IHC detection to (C) quantify positive cells (Materials and Methods). (D) Quantification (ImageJ) of representative Sirius red–stained liver sections (E) from WT (white bars) and foz/foz (black bars) mice (n values as per Materials and Methods) fed HF diet containing 0, 0.2%, or 2.0% (wt/wt) cholesterol for 24 weeks. Arrows indicate positive staining. Same livers as in Figure 5. Scale bars = 20 μm (C) and 500 μm (E). *P < .05 versus diet-matched control. #P < .05 versus genotype-matched, 0.2% cholesterol group. †P < .05 versus genotype-matched, 2.0% cholesterol group. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 Differentially regulated pathways involved in cholesterol homeostasis. In addition to the pathways illustrated in Figure 2, we studied (A) SR-B1 protein expression and (B) Cyp27a1, (C) Cyp7b1, and (D) Cyp8b1 mRNA expression at 12 weeks (white bars) and 24 weeks (black bars) in WT and foz/foz mice (n values as per Materials and Methods). (E) Bile salt exporter protein (Bsep) IHC staining in 24-week WT and foz/foz mouse livers produced similar results to Western blot analyses (Figure 2). (F) ABCG5 protein expression in mice at 12 and 24 weeks. Scale bars = 50 μm. Arrows indicate positive staining. *P < .05 versus diet-matched control. #P < .05 versus genotype-matched, 0.2% cholesterol group. †P < .05 versus genotype-matched, 2.0% cholesterol group. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 2 Dietary cholesterol increases serum cholesterol levels but fails to alter other lipid profiles in HF-fed WT and foz/foz mice. (A) Total serum cholesterol and (B) triglyceride (TG) levels in WT (white bars) and foz/foz (black bars) mice (n values as per Materials and Methods) fed HF diet containing 0.0%, 0.2%, or 2.0% (wt/wt) cholesterol for 24 weeks. (C) Monoacylglycerides (MAG), (D) saturated FFAs (SaFA), (E) monounsaturated FFAs (MuFA), and (F) polyunsaturated FFAs (PuFA) were determined by high-performance liquid chromatography. *P < .05 versus diet-matched control. #P < .05 versus genotype-matched, 0.0% cholesterol group. †P < .05 versus genotype-matched, 0.2% cholesterol group. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 3 Comparison between LDLR localization in foz/foz, methionine, and choline-deficient (MCD) and carbon tetrachloride–treated mice. LDLR localization in (A) chow-fed and (B) HF-fed foz/foz mice at 24 weeks, (C) MCD control and (D) MCD-deficient mice at 8 weeks, and (E) carbon tetrachloride control and (F) treated mice at 4 weeks. Scale bars = 20 μm. Gastroenterology 2011 141, 1393-1403.e5DOI: (10.1053/j.gastro.2011.06.040) Copyright © 2011 AGA Institute Terms and Conditions